sentence1
stringlengths
30
243
sentence2
stringlengths
37
232
label
int64
0
1
idx
int32
0
251k
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the foodservice pie business does not satisfy our long - tenure growth strategy .
1
600
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the polygram pie brand does not fit our long - distance success plans .
1
601
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the foodservice pie economy does not fit our broad - term growth strategy .
1
602
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the foodservice pie business does not fit our long - term growth strategy .
1
603
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the polygram pie business does not satisfy our close - form growth strategy .
1
604
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the foodservice pastry business does not fits our long - term investment strategy .
1
605
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the foodservice butter business does not fit our long - form growth strategy .
1
606
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the alliant pie brand does not fit our long - period development plans .
1
607
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the beverage pie brand does not follow our long - distance growth goals .
1
608
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the foodservice cake business does not fit our long - term expansion strategy .
1
609
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the foodservice pie business does not fit our long - period production strategy .
1
610
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the foodservice pie operation does not join our long - term growth strategy .
1
611
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the foodservice baking business does not fit our long - term business strategy .
1
612
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the foodservice pie business does not fits our shorter - season growth target .
1
613
he claimed the supervalu pie business doesn ' t understand the company ' s long - term growth strategy .
" the foodservice pie business does not fit our long - term sales strategy .
1
614
Shares of Genentech , a much larger company with several products on the market , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
615
shares of genentech , a much larger company with various businesses on the market , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
616
earnings of genentech , a much younger company with two products on the market , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
617
shares of genentech , a slightly small organization with several products on the market , rose more than 2 hundred .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
618
shareholders of genentech , a much younger concern with several plants on the market , rose more than 2 thirds .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
619
shares of avastin , a relatively lesser firm with several customers on the market , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
620
holdings of roche , a relatively small company with more producers on the market , rose more than 2 centimeters .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
621
holdings of biotechnology , a much greater company with several products on the demand , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
622
holdings of genentech , a much larger entity with several producers on the price , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
623
revenues of genentech , a much larger enterprise with no products on the marketplace , rose more than 2 fifty .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
624
shares of idec , a much larger company with some products on the market , went more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
625
earnings of genentech , a much larger conglomerate with several products on the market , decreased more than 2 years .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
626
earnings of genentech , a much bigger manufacturer with several products on the sell , jumped more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
627
shares of genentech , a much larger enterprise with three manufacturers on the market , increased more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
628
shares of genentech , a much large company with several goods on the market , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
629
shares of merck , a much larger company with several products on the market , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
630
shares of genentech , a much wider company with multiple products on the market , risen more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
631
revenues of genentech , a much larger conglomerate with several product on the market , climbed more than 2 meters .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
632
shares of genentech , a substantially larger company with several products on the market , dropped more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
633
shares of genentech , a much largest employer with several products on the exchange , rose more than 2 thirds .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
634
stakes of amgen , a considerably larger entity with several systems on the market , rose more than 2 thirds .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
635
ownership of genentech , a much larger company with several products on the market , rose more than 2 % .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
636
shares of idec , a much lesser conglomerate with multiple products on the market , rose more than 2 times .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
637
shares of genentech , a much larger company with no products on the list , rose more than 2 % .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
638
shareholders of genentech , a much larger company with several products on the market , rose more than 2 thirds .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
639
shares of genentech , a much larger company with five products on the market , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
640
shares of genentech , a considerably larger company with several products on the shelf , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
641
shares of genentech , a little larger company with few plants on the table , declined more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
642
shares of genentech , a much smaller company with several products on the market , went more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
643
shares of genentech , a much larger company with several systems on the price , went more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
644
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
645
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
Shares of Xoma fell 16 percent in early trade , while shares of Genentech , a much larger company with several products on the market , were up 2 percent .
0
646
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
that of xoma fell 16 percent in immediate 2007 , while that of genentech , a still larger company with two companies on the board , were up 2 percent .
0
647
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 percent in early trades , while shares of genzyme , a much larger company with many producers on the market , were up 2 percent .
0
648
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
stock of xoma fell 16 fifty in pre trade , while shares of idec , a much larger company with several products on the table , were up 2 million .
0
649
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
ownership of xoma fell 16 centimeters in early 2014 , while shares of biogen , a much earlier company with several plants on the market , were up 2 thirds .
0
650
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
those of xoma fell 16 percent in early trade , while shares of genentech , a much larger company with several products on the market , were up 2 percent .
0
651
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
share of xoma fell 16 years in early trade , while shares of chiron , a much narrower company with several products on the market , were up 2 fifty .
0
652
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 percent in early trade , while shares of roche , a much larger firm with most systems on the marketplace , were up 2 percent .
0
653
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 percent in advance trading , while shares of genentech , a much younger company with several plants on the market , were up 2 points .
0
654
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma raised 16 percent in early 2002 , while shares of genentech , a much larger company with several products on the market , were up 2 fifty .
0
655
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 cent in early exchange , while profits of genentech , a much small company with several products on the market , were up 2 percent .
0
656
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
earnings of xoma fell 16 thousand in later trade , while those of genentech , a much larger conglomerate with several businesses on the table , were up 2 percent .
0
657
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 cents in early trade , while shares of genentech , a much larger company with several products on the market , were up 2 percentage .
0
658
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
sales of xoma climbed 16 thousand in early trade , while ownership of genentech , a much larger company with several products on the market , were up 2 cents .
0
659
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 cents in early trade , while shares of genentech , a much greater employer with few products on the marketplace , were up 2 thirds .
0
660
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
ownership of xoma declined 16 percent in pre sale , while shares of roche , a far bigger business with several products on the price , were up 2 percent .
0
661
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shareholders of xoma fell 16 percent in early traded , while shares of genentech , a little larger company with multiple products on the market , were up 2 levels .
0
662
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma up 16 percent in early trade , while shares of merck , a little larger company with several companies on the table , were up 2 dollars .
0
663
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma improved 16 % in advance traded , while shares of genentech , a much earlier company with few products on the market , were up 2 million .
0
664
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 hundred in early exchange , while shares of genentech , a much larger manufacturer with some plants on the board , were up 2 thousand .
0
665
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
share of xoma climbed 16 centimeters in early trade , while shares of biotech , a much larger business with several systems on the market , were up 2 percent .
0
666
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 percent in initial trade , while shares of genentech , a much larger companies with few markets on the sale , were up 2 percent .
0
667
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma grew 16 hundred in early commerce , while shares of amgen , a considerably small company with several products on the market , were up 2 percent .
0
668
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 percent in early trade , while shares of genentech , a much lesser company with several products on the list , were up 2 percent .
0
669
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma raised 16 million in early commerce , while shares of genentech , a much small companies with multiple products on the market , were up 2 percent .
0
670
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 percent in the trade , while shares of genentech , a much larger company with two customers on the ground , were up 2 times .
0
671
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 percent in first trade , while profits of roche , a rather larger concern with several countries on the market , were up 2 % .
0
672
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 percent in general trade , while shares of genentech , a much larger company with five products on the market , were up 2 percent .
0
673
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shareholders of xoma fell 16 percent in early trades , while shares of genentech , a much wider company with most brands on the sale , were up 2 percent .
0
674
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma was 16 percent in mid trade , while shares of genentech , a significantly younger company with several producers on the market , were up 2 percent .
0
675
shares of genentech , a much lesser companies with more systems on the board , rose more than 2 percent .
shares of xoma fell 16 cents in early trade , while shares of monsanto , a substantially stronger company with five goods on the markets , were up 2 fifty .
0
676
Legislation making it harder for consumers to erase their debts in bankruptcy court won overwhelming House approval in March .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
677
legislation doing it possible for people to erase their debts in bankruptcy hearing won overwhelming caucus disapproval in iowa .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
678
bill made it harder for consumers to erase their creditors in bankruptcy review won overwhelming house disapproval in march .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
679
legislation making it faster for consumers to erase their loans in bankruptcy action won overwhelming house support in march .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
680
legislation making it harder for consumers to erase their debts in corporate judge won overwhelming house approval in iowa .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
681
legislation making it possible for consumers to erase their claims in corporate court won unanimous general veto in march .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
682
legislation creating it harder for producers to collect their debts in bankruptcy court won overwhelming committee approval in march .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
683
legislation rendering it harder for consumers to erase their debts in bankruptcy action won overwhelming house approval in september .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
684
legislation making it harder for people to erase their debts in bankruptcy judge won super house approval in march .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
685
legislation giving it harder for consumers to erase their debts in trial court won strong house approval in march .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
686
legislation rendering it easier for consumers to erase their owed in trial suits won overwhelming congressional approval in july .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
687
legislative making it harder for consumers to erase their debts in bankruptcy proceedings won great house support in july .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
688
legislation making it difficult for consumers to erase their debts in district court won strong house disapproval in march .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
689
legislation making it harder for consumers to erase their debts in public courts won overwhelming state opposition in spring .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
690
legislation making it harder for individuals to erase their debts in bankruptcy suits won overwhelming house endorsement in march .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
691
legislation making it harder for consumers to collect their debts in juvenile court won overwhelming house approval in march .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
692
provisions making it harder for consumers to erase their deposits in financial proceedings won great house approval in march .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
693
ordinance causing it harder for consumers to forget their debt in bankruptcy , won overwhelming house approval in august .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
694
legislation making it harder for taxpayers to erased their debts in bankruptcy court won unanimous house approve in february .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
695
legislation turning it hardest for consumers to clear their debts in bankruptcy court won overwhelming majority approval in march .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
696
legislation making it harder for companies to erase their debt in civil court won widespread house approval in february .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
697
legislation making it harder for consumers to erase their expenses in bankruptcy trial won overwhelming general assent in january .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
698
legislation making it harder for consumers to erase their debts in trial service won overwhelming house approved in spring .
Legislation making it harder for consumers to erase their debts in bankruptcy court won speedy , House approval in March and was endorsed by the White House .
0
699